| Year |
Citation |
Score |
| 2024 |
Ali M, Garcia P, Lunkes LP, Sciortino A, Thomas M, Heurtaux T, Grzyb K, Halder R, Coowar D, Skupin A, Buée L, Blum D, Buttini M, Glaab E. Single cell transcriptome analysis of the THY-Tau22 mouse model of Alzheimer's disease reveals sex-dependent dysregulations. Cell Death Discovery. 10: 119. PMID 38453894 DOI: 10.1038/s41420-024-01885-9 |
0.312 |
|
| 2023 |
Siew JJ, Chen HM, Chiu FL, Lee CW, Chang YM, Chen HL, Nguyen TNA, Liao HT, Liu M, Hagar HT, Sun YC, Lai HL, Kuo MH, Blum D, Buée L, et al. Galectin-3 aggravates microglial activation and tau transmission in tauopathy. The Journal of Clinical Investigation. PMID 37988169 DOI: 10.1172/JCI165523 |
0.429 |
|
| 2023 |
Hartnell IJ, Woodhouse D, Jasper W, Mason L, Marwaha P, Graffeuil M, Lau LC, Norman JL, Chatelet DS, Buee L, Nicoll JAR, Blum D, Dorothee G, Boche D. Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology. Brain : a Journal of Neurology. PMID 37703311 DOI: 10.1093/brain/awad309 |
0.309 |
|
| 2023 |
Ghazal M, Susloparova A, Lefebvre C, Daher Mansour M, Ghodhbane N, Melot A, Scholaert C, Guérin D, Janel S, Barois N, Colin M, Buée L, Yger P, Halliez S, Coffinier Y, et al. Electropolymerization processing of side-chain engineered EDOT for high performance microelectrode arrays. Biosensors & Bioelectronics. 237: 115538. PMID 37506488 DOI: 10.1016/j.bios.2023.115538 |
0.611 |
|
| 2023 |
Perbet R, Zufferey V, Leroux E, Parietti E, Espourteille J, Culebras L, Perriot S, Du Pasquier R, Bégard S, Deramecourt V, Déglon N, Toni N, Buée L, Colin M, Richetin K. Tau Transfer via Extracellular Vesicles Disturbs the Astrocytic Mitochondrial System. Cells. 12. PMID 37048058 DOI: 10.3390/cells12070985 |
0.713 |
|
| 2023 |
Tautou M, Descamps F, Larchanché PE, Buée L, El Bakali J, Melnyk P, Sergeant N. A Polyaminobiaryl-Based β-secretase Modulator Alleviates Cognitive Impairments, Amyloid Load, Astrogliosis, and Neuroinflammation in APP/PSEN1 Mice Model of Amyloid Pathology. International Journal of Molecular Sciences. 24. PMID 36982363 DOI: 10.3390/ijms24065285 |
0.352 |
|
| 2023 |
Ghazal M, Scholaert C, Dumortier C, Lefebvre C, Barois N, Janel S, Tarhan MC, Colin M, Buée L, Halliez S, Pecqueur S, Cofinier Y, Alibart F, Yger P. Precision of neuronal localization in 2D cell cultures by using high-performance electropolymerized microelectrode arrays correlated with optical imaging. Biomedical Physics & Engineering Express. PMID 36745905 DOI: 10.1088/2057-1976/acb93e |
0.638 |
|
| 2022 |
Launay A, Nebie O, Vijaya Shankara J, Lebouvier T, Buée L, Faivre E, Blum D. The role of adenosine A receptors in Alzheimer's disease and tauopathies. Neuropharmacology. 226: 109379. PMID 36572177 DOI: 10.1016/j.neuropharm.2022.109379 |
0.32 |
|
| 2022 |
Denechaud M, Geurs S, Comptdaer T, Bégard S, Garcia-Núñez A, Pechereau LA, Bouillet T, Vermeiren Y, De Deyn PP, Perbet R, Deramecourt V, Maurage CA, Vanderhaegen M, Vanuytven S, Lefebvre B, et al. Tau promotes oxidative stress-associated cycling neurons in S phase as a pro-survival mechanism: possible implication for Alzheimer's disease. Progress in Neurobiology. 102386. PMID 36481386 DOI: 10.1016/j.pneurobio.2022.102386 |
0.728 |
|
| 2022 |
Bouillet T, Ciba M, Lourenço Alves C, Rodrigues FA, Thielemann C, Colin M, Buée L, Halliez S. Revisiting the involvement of tau in complex neural network remodeling: analysis of the extracellular neuronal activity in organotypic brain slice co-cultures. Journal of Neural Engineering. PMID 36374001 DOI: 10.1088/1741-2552/aca261 |
0.725 |
|
| 2022 |
Lam S, Hérard AS, Boluda S, Petit F, Eddarkaoui S, Cambon K, Picq JL, Buée L, Duyckaerts C, Haïk S, Dhenain M. Pathological changes induced by Alzheimer's brain inoculation in amyloid-beta plaque-bearing mice. Acta Neuropathologica Communications. 10: 112. PMID 35974399 DOI: 10.1186/s40478-022-01410-y |
0.39 |
|
| 2022 |
Benderradji H, Kraiem S, Courty E, Eddarkaoui S, Bourouh C, Faivre E, Rolland L, Caron E, Besegher M, Oger F, Boschetti T, Carvalho K, Thiroux B, Gauvrit T, Nicolas E, et al. Impaired Glucose Homeostasis in a Tau Knock-In Mouse Model. Frontiers in Molecular Neuroscience. 15: 841892. PMID 35250480 DOI: 10.3389/fnmol.2022.841892 |
0.337 |
|
| 2022 |
da Costa PJ, Hamdane M, Buée L, Martin F. Tau mRNA Metabolism in Neurodegenerative Diseases: A Tangle Journey. Biomedicines. 10. PMID 35203451 DOI: 10.3390/biomedicines10020241 |
0.411 |
|
| 2022 |
Arandel L, Matloka M, Klein AF, Rau F, Sureau A, Ney M, Cordier A, Kondili M, Polay-Espinoza M, Naouar N, Ferry A, Lemaitre M, Begard S, Colin M, Lamarre C, et al. Reversal of RNA toxicity in myotonic dystrophy via a decoy RNA-binding protein with high affinity for expanded CUG repeats. Nature Biomedical Engineering. 6: 207-220. PMID 35145256 DOI: 10.1038/s41551-021-00838-2 |
0.623 |
|
| 2022 |
Danis C, Dupré E, Zejneli O, Caillierez R, Arrial A, Bégard S, Mortelecque J, Eddarkaoui S, Loyens A, Cantrelle FX, Hanoulle X, Rain JC, Colin M, Buée L, Landrieu I. Inhibition of Tau seeding by targeting Tau nucleation core within neurons with a single domain antibody fragment. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 35007758 DOI: 10.1016/j.ymthe.2022.01.009 |
0.748 |
|
| 2021 |
Leroux É, Perbet R, Buée L, Colin M. [Extracellular vesicles in the central nervous system]. Medecine Sciences : M/S. 37: 1133-1138. PMID 34928217 DOI: 10.1051/medsci/2021205 |
0.661 |
|
| 2021 |
Lam S, Petit F, Hérard AS, Boluda S, Eddarkaoui S, Guillermier M, Buée L, Duyckaerts C, Haïk S, Picq JL, Dhenain M. Transmission of amyloid-beta and tau pathologies is associated with cognitive impairments in a primate. Acta Neuropathologica Communications. 9: 165. PMID 34641980 DOI: 10.1186/s40478-021-01266-8 |
0.367 |
|
| 2021 |
Sexton C, Snyder H, Beher D, Boxer AL, Brannelly P, Brion JP, Buée L, Cacace AM, Chételat G, Citron M, DeVos SL, Diaz K, Feldman HH, Frost B, Goate AM, et al. Current directions in tau research: Highlights from Tau 2020. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34581500 DOI: 10.1002/alz.12452 |
0.521 |
|
| 2021 |
Leroux E, Perbet R, Caillierez R, Richetin K, Lieger S, Espourteille J, Bouillet T, Bégard S, Danis C, Loyens A, Toni N, Déglon N, Deramecourt V, Schraen-Maschke S, Buée L, et al. Extracellular vesicles: Major actors of heterogeneity in tau spreading among human tauopathies. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 34563677 DOI: 10.1016/j.ymthe.2021.09.020 |
0.74 |
|
| 2021 |
Carvalho K, Martin E, Ces A, Sarrazin N, Lagouge-Roussey P, Nous C, Boucherit L, Youssef I, Prigent A, Faivre E, Eddarkaoui S, Gauvrit T, Vieau D, Boluda S, Huin V, et al. P2X7-deficiency improves plasticity and cognitive abilities in a mouse model of Tauopathy. Progress in Neurobiology. 102139. PMID 34391810 DOI: 10.1016/j.pneurobio.2021.102139 |
0.455 |
|
| 2021 |
Tautou M, Eddarkaoui S, Descamps F, Larchanché PE, El Bakali J, Goveas LM, Dumoulin M, Lamarre C, Blum D, Buée L, Melnyk P, Sergeant N. A ß-Secretase Modulator Decreases Tau Pathology and Preserves Short-Term Memory in a Mouse Model of Neurofibrillary Degeneration. Frontiers in Pharmacology. 12: 679335. PMID 34267657 DOI: 10.3389/fphar.2021.679335 |
0.335 |
|
| 2021 |
Chang CP, Chang YG, Chuang PY, Nguyen TNA, Wu KC, Chou FY, Cheng SJ, Chen HM, Jin LW, Carvalho K, Huin V, Buée L, Liao YF, Lin CJ, Blum D, et al. Equilibrative nucleoside transporter 1 inhibition rescues energy dysfunction and pathology in a model of tauopathy. Acta Neuropathologica Communications. 9: 112. PMID 34158119 DOI: 10.1186/s40478-021-01213-7 |
0.356 |
|
| 2021 |
Vautheny A, Duwat C, Auregan G, Joséphine C, Hérard AS, Jan C, Mitja J, Gipchtein P, Gaillard MC, Buée L, Blum D, Hantraye P, Bonvento G, Brouillet E, Cambon K, et al. THY-Tau22 mouse model accumulates more tauopathy at late stage of the disease in response to microglia deactivation through TREM2 deficiency. Neurobiology of Disease. 105398. PMID 34019997 DOI: 10.1016/j.nbd.2021.105398 |
0.332 |
|
| 2020 |
Degiorgis L, Karatas M, Sourty M, Faivre E, Lamy J, Noblet V, Bienert T, Reisert M, von Elverfeldt D, Buée L, Blum D, Boutillier AL, Armspach JP, Blanc F, Harsan LA. Brain network remodelling reflects tau-related pathology prior to memory deficits in Thy-Tau22 mice. Brain : a Journal of Neurology. PMID 33184651 DOI: 10.1093/brain/awaa312 |
0.329 |
|
| 2020 |
Richetin K, Steullet P, Pachoud M, Perbet R, Parietti E, Maheswaran M, Eddarkaoui S, Bégard S, Pythoud C, Rey M, Caillierez R, Q Do K, Halliez S, Bezzi P, Buée L, et al. Tau accumulation in astrocytes of the dentate gyrus induces neuronal dysfunction and memory deficits in Alzheimer's disease. Nature Neuroscience. PMID 33169029 DOI: 10.1038/s41593-020-00728-x |
0.731 |
|
| 2020 |
Ahmed T, Van der Jeugd A, Caillierez R, Buée L, Blum D, D'Hooge R, Balschun D. Chronic Sodium Selenate Treatment Restores Deficits in Cognition and Synaptic Plasticity in a Murine Model of Tauopathy. Frontiers in Molecular Neuroscience. 13: 570223. PMID 33132838 DOI: 10.3389/fnmol.2020.570223 |
0.351 |
|
| 2020 |
Gomez-Murcia V, Sandau U, Ferry B, Parrot S, Laurent C, Basquin M, Buée L, Boison D, Blum D. Hyperexcitability and seizures in the THY-Tau22 mouse model of tauopathy. Neurobiology of Aging. 94: 265-270. PMID 32679397 DOI: 10.1016/J.Neurobiolaging.2020.06.004 |
0.411 |
|
| 2020 |
Verelst J, Geukens N, Eddarkaoui S, Vliegen D, De Smidt E, Rosseels J, Franssens V, Molenberghs S, Francois C, Stoops E, Bjerke M, Engelborghs S, Laghmouchi M, Carmans S, Buée L, et al. A Novel Tau Antibody Detecting the First Amino-Terminal Insert Reveals Conformational Differences Among Tau Isoforms. Frontiers in Molecular Biosciences. 7: 48. PMID 32296712 DOI: 10.3389/Fmolb.2020.00048 |
0.431 |
|
| 2020 |
Zheng J, Akbari M, Schirmer C, Reynaert ML, Loyens A, Lefebvre B, Buée L, Croteau DL, Galas MC, Bohr VA. Hippocampal tau oligomerization early in tau pathology coincides with a transient alteration of mitochondrial homeostasis and DNA repair in a mouse model of tauopathy. Acta Neuropathologica Communications. 8: 25. PMID 32131898 DOI: 10.1186/S40478-020-00896-8 |
0.496 |
|
| 2020 |
Homa M, Loyens A, Eddarkaoui S, Faivre E, Deramecourt V, Maurage CA, Buée L, Huin V, Sablonnière B. The TMEM240 Protein, Mutated in SCA21, Is Expressed in Purkinje Cells and Synaptic Terminals. Cerebellum (London, England). PMID 32002801 DOI: 10.1007/S12311-020-01112-Y |
0.313 |
|
| 2020 |
Sierksma A, Lu A, Mancuso R, Fattorelli N, Thrupp N, Salta E, Zoco J, Blum D, Buée L, De Strooper B, Fiers M. Novel Alzheimer risk genes determine the microglia response to amyloid-β but not to TAU pathology. Embo Molecular Medicine. e10606. PMID 31951107 DOI: 10.15252/Emmm.201910606 |
0.414 |
|
| 2020 |
Ando K, De Decker R, Vergara C, Yilmaz Z, Mansour S, Suain V, Sleegers K, de Fisenne MA, Houben S, Potier MC, Duyckaerts C, Watanabe T, Buée L, Leroy K, Brion JP. Picalm reduction exacerbates tau pathology in a murine tauopathy model. Acta Neuropathologica. PMID 31925534 DOI: 10.1007/S00401-020-02125-X |
0.546 |
|
| 2020 |
Susloparova A, Halliez S, Begard S, Colin M, Buée L, Pecqueur S, Alibart F, Thomy V, Arscott S, Pallecchi E, Coffinier Y. Low impedance and highly transparent microelectrode arrays (MEA) for in vitro neuron electrical activity probing Sensors and Actuators B-Chemical. 128895. DOI: 10.1016/J.Snb.2020.128895 |
0.667 |
|
| 2019 |
Buee L. Dementia Therapy Targeting Tau. Advances in Experimental Medicine and Biology. 1184: 407-416. PMID 32096053 DOI: 10.1007/978-981-32-9358-8_30 |
0.531 |
|
| 2019 |
Gratuze M, Joly-Amado A, Buee L, Vieau D, Blum D. Tau, Diabetes and Insulin. Advances in Experimental Medicine and Biology. 1184: 259-287. PMID 32096044 DOI: 10.1007/978-981-32-9358-8_21 |
0.554 |
|
| 2019 |
Fernandez-Gomez F, Tran H, Dhaenens CM, Caillet-Boudin ML, Schraen-Maschke S, Blum D, Sablonnière B, Buée-Scherrer V, Buee L, Sergeant N. Myotonic Dystrophy: an RNA Toxic Gain of Function Tauopathy? Advances in Experimental Medicine and Biology. 1184: 207-216. PMID 32096040 DOI: 10.1007/978-981-32-9358-8_17 |
0.427 |
|
| 2019 |
Galas MC, Bonnefoy E, Buee L, Lefebvre B. Emerging Connections Between Tau and Nucleic Acids. Advances in Experimental Medicine and Biology. 1184: 135-143. PMID 32096035 DOI: 10.1007/978-981-32-9358-8_12 |
0.456 |
|
| 2019 |
Hector A, McAnulty C, Piché-Lemieux MÉ, Alves-Pires C, Buée-Scherrer V, Buée L, Brouillette J. Tau hyperphosphorylation induced by the anesthetic agent ketamine/xylazine involved the calmodulin-dependent protein kinase II. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 31908108 DOI: 10.1096/Fj.201902135R |
0.441 |
|
| 2019 |
Faldini E, Ahmed T, Bueé L, Blum D, Balschun D. Tau- but not Aß -pathology enhances NMDAR-dependent depotentiation in AD-mouse models. Acta Neuropathologica Communications. 7: 202. PMID 31815648 DOI: 10.1186/S40478-019-0813-4 |
0.437 |
|
| 2019 |
Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, Schwartz S, Albasset S, McManus RM, Tejera D, Griep A, Santarelli F, Brosseron F, Opitz S, Stunden J, et al. NLRP3 inflammasome activation drives tau pathology. Nature. PMID 31748742 DOI: 10.1038/S41586-019-1769-Z |
0.5 |
|
| 2019 |
Colin M, Dujardin S, Schraen-Maschke S, Meno-Tetang G, Duyckaerts C, Courade JP, Buée L. From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy. Acta Neuropathologica. PMID 31686182 DOI: 10.1007/S00401-019-02087-9 |
0.841 |
|
| 2019 |
Zappettini S, Faivre E, Ghestem A, Carrier S, Buée L, Blum D, Esclapez M, Bernard C. Caffeine Consumption During Pregnancy Accelerates the Development of Cognitive Deficits in Offspring in a Model of Tauopathy. Frontiers in Cellular Neuroscience. 13: 438. PMID 31680863 DOI: 10.3389/Fncel.2019.00438 |
0.363 |
|
| 2019 |
Carvalho K, Faivre E, Pietrowski MJ, Marques X, Gomez-Murcia V, Deleau A, Huin V, Hansen JN, Kozlov S, Danis C, Temido-Ferreira M, Coelho JE, Mériaux C, Eddarkaoui S, Gras SL, et al. Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor. Brain : a Journal of Neurology. PMID 31599329 DOI: 10.1093/Brain/Awz288 |
0.496 |
|
| 2019 |
Gary C, Lam S, Hérard AS, Koch JE, Petit F, Gipchtein P, Sawiak SJ, Caillierez R, Eddarkaoui S, Colin M, Aujard F, Deslys JP, Brouillet E, Buée L, et al. Encephalopathy induced by Alzheimer brain inoculation in a non-human primate. Acta Neuropathologica Communications. 7: 126. PMID 31481130 DOI: 10.1186/S40478-019-0771-X |
0.758 |
|
| 2019 |
Dupr Eacute E, Danis C, Arrial A, Hanoulle X, Homa M, Cantrelle FX, Merzougui H, Colin M, Rain JC, Buee L, Landrieu I. Single domain antibody fragments as new tools for detection of the neuronal tau protein in cells and in mice studies. Acs Chemical Neuroscience. PMID 31380615 DOI: 10.1021/Acschemneuro.9B00217 |
0.771 |
|
| 2019 |
Loera-Valencia R, Cedazo-Minguez A, Kenigsberg P, Page G, Duarte A, Giusti P, Zusso M, Robert P, Frisoni GB, Cattaneo A, Zille M, Boltze J, Cartier N, Buee L, Johansson G, et al. Current and emerging avenues for Alzheimer's disease drug targets. Journal of Internal Medicine. PMID 31286586 DOI: 10.1111/Joim.12959 |
0.45 |
|
| 2019 |
Corvol JC, Buée L. A new step towards targeting tau. The Lancet. Neurology. 18: 517-518. PMID 31122487 DOI: 10.1016/S1474-4422(19)30161-9 |
0.378 |
|
| 2019 |
Albert M, Mairet-Coello G, Danis C, Lieger S, Caillierez R, Carrier S, Skrobala E, Landrieu I, Michel A, Schmitt M, Citron M, Downey P, Courade JP, Buée L, Colin M. Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody. Brain : a Journal of Neurology. PMID 31038156 DOI: 10.1093/Brain/Awz100 |
0.772 |
|
| 2019 |
Sergeant N, Vingtdeux V, Eddarkaoui S, Gay M, Evrard C, Le Fur N, Laurent C, Caillierez R, Obriot H, Larchanché PE, Farce A, Coevoet M, Carato P, Kouach M, Descat A, et al. New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's disease. Neurobiology of Disease. PMID 30928644 DOI: 10.1016/J.Nbd.2019.03.028 |
0.463 |
|
| 2019 |
Domise M, Sauvé F, Didier S, Caillerez R, Bégard S, Carrier S, Colin M, Marinangeli C, Buée L, Vingtdeux V. Neuronal AMP-activated protein kinase hyper-activation induces synaptic loss by an autophagy-mediated process. Cell Death & Disease. 10: 221. PMID 30833547 DOI: 10.1038/S41419-019-1464-X |
0.705 |
|
| 2019 |
Fichou Y, Al-Hilaly YK, Devred F, Smet-Nocca C, Tsvetkov PO, Verelst J, Winderickx J, Geukens N, Vanmechelen E, Perrotin A, Serpell L, Hanseeuw BJ, Medina M, Buée L, Landrieu I. The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention? Acta Neuropathologica Communications. 7: 31. PMID 30823892 DOI: 10.1186/S40478-019-0682-X |
0.468 |
|
| 2019 |
Houben S, Leroy K, Ando K, Yilmaz Z, Widomski C, Buée L, Brion JP. Genetic ablation of tau in postnatal neurons rescues decreased adult hippocampal neurogenesis in a tauopathy model. Neurobiology of Disease. PMID 30818066 DOI: 10.1016/J.Nbd.2019.02.021 |
0.448 |
|
| 2019 |
Jadhav S, Avila J, Schöll M, Kovacs GG, Kövari E, Skrabana R, Evans LD, Kontsekova E, Malawska B, de Silva R, Buee L, Zilka N. A walk through tau therapeutic strategies. Acta Neuropathologica Communications. 7: 22. PMID 30767766 DOI: 10.1186/S40478-019-0664-Z |
0.542 |
|
| 2019 |
Leboucher A, Ahmed T, Caron E, Tailleux A, Raison S, Joly-Amado A, Marciniak E, Carvalho K, Hamdane M, Bantubungi K, Lancel S, Eddarkaoui S, Caillierez R, Vallez E, Staels B, et al. Brain insulin response and peripheral metabolic changes in a Tau transgenic mouse model. Neurobiology of Disease. PMID 30665005 DOI: 10.1016/J.Nbd.2019.01.008 |
0.446 |
|
| 2019 |
Shrivastava AN, Redeker V, Pieri L, Bousset L, Renner M, Madiona K, Mailhes-Hamon C, Coens A, Buée L, Hantraye P, Triller A, Melki R. Clustering of Tau fibrils impairs the synaptic composition of α3-Na/K-ATPase and AMPA receptors. The Embo Journal. PMID 30630857 DOI: 10.15252/Embj.201899871 |
0.43 |
|
| 2019 |
Buee L, Danis C, Dupre E, Arrial A, Cantrelle F, Rain J, Colin M, Hanoulle X, Landrieu I. Nanobodies (VHHs) for targeting tau in Alzheimer's disease and tauopathies Ibro Reports. 6. DOI: 10.1016/J.Ibror.2019.07.325 |
0.742 |
|
| 2018 |
Joly-Amado A, Gratuze M, Benderradji H, Vieau D, Buée L, Blum D. [Brain insulin signaling and Tau: impact for Alzheimer's disease and Tauopathies]. Medecine Sciences : M/S. 34: 929-935. PMID 30526837 DOI: 10.1051/Medsci/2018238 |
0.424 |
|
| 2018 |
Evrard C, Kienlen-Campard P, Coevoet M, Opsomer R, Tasiaux B, Melnyk P, Octave JN, Buée L, Sergeant N, Vingtdeux V. Contribution of the Endosomal-Lysosomal and Proteasomal Systems in Amyloid-β Precursor Protein Derived Fragments Processing. Frontiers in Cellular Neuroscience. 12: 435. PMID 30524243 DOI: 10.3389/Fncel.2018.00435 |
0.387 |
|
| 2018 |
Dujardin S, Bégard S, Caillierez R, Lachaud C, Carrier S, Lieger S, Gonzalez JA, Deramecourt V, Déglon N, Maurage CA, Frosch MP, Hyman BT, Colin M, Buée L. Different tau species lead to heterogeneous tau pathology propagation and misfolding. Acta Neuropathologica Communications. 6: 132. PMID 30497516 DOI: 10.1186/S40478-018-0637-7 |
0.843 |
|
| 2018 |
Marinangeli C, Didier S, Ahmed T, Caillerez R, Domise M, Laloux C, Bégard S, Carrier S, Colin M, Marchetti P, Ghesquière B, Balschun D, Buée L, Kluza J, Vingtdeux V. AMP-Activated Protein Kinase Is Essential for the Maintenance of Energy Levels during Synaptic Activation. Iscience. 9: 1-13. PMID 30368077 DOI: 10.1016/J.Isci.2018.10.006 |
0.689 |
|
| 2018 |
Duron E, Vidal JS, Grousselle D, Gabelle A, Lehmann S, Pasquier F, Buée L, Allinquant B, Schraen-Maschke S, Baret C, Rigaud AS, Hanon O, Epelbaum J. Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aβ and Tau Proteins in Elderly Patients With Mild Cognitive Impairment. Frontiers in Aging Neuroscience. 10: 297. PMID 30327597 DOI: 10.3389/Fnagi.2018.00297 |
0.483 |
|
| 2018 |
Benhelli-Mokrani H, Mansuroglu Z, Chauderlier A, Albaud B, Gentien D, Sommer S, Schirmer C, Laqueuvre L, Josse T, Buée L, Lefebvre B, Galas MC, Souès S, Bonnefoy E. Genome-wide identification of genic and intergenic neuronal DNA regions bound by Tau protein under physiological and stress conditions. Nucleic Acids Research. PMID 30321409 DOI: 10.1093/Nar/Gky929 |
0.459 |
|
| 2018 |
Sierksma A, Lu A, Salta E, Vanden Eynden E, Callaerts-Vegh Z, D'Hooge R, Blum D, Buée L, Fiers M, De Strooper B. Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology. Molecular Neurodegeneration. 13: 54. PMID 30314521 DOI: 10.1186/S13024-018-0285-1 |
0.409 |
|
| 2018 |
Chatterjee S, Cassel R, Schneider-Anthony A, Merienne K, Cosquer B, Tzeplaeff L, Halder Sinha S, Kumar M, Chaturbedy P, Eswaramoorthy M, Le Gras S, Keime C, Bousiges O, Dutar P, Petsophonsakul P, et al. Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator. Embo Molecular Medicine. PMID 30275019 DOI: 10.15252/Emmm.201708587 |
0.328 |
|
| 2018 |
Gay M, Evrard C, Descamps F, Carato P, Renault N, Coevoet M, Eddarkaoui S, Baud C, Larchanché PE, Buée L, El Bakali J, Vingtdeux V, Sergeant N, Melnyk P. A phenotypic approach to the discovery of compounds that promote non-amyloidogenic processing of the amyloid precursor protein: Toward a new profile of indirect β-secretase inhibitors. European Journal of Medicinal Chemistry. 159: 104-125. PMID 30268822 DOI: 10.1016/J.Ejmech.2018.08.092 |
0.334 |
|
| 2018 |
Cellai L, Carvalho K, Faivre E, Deleau A, Vieau D, Buée L, Blum D, Mériaux C, Gomez-Murcia V. The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer's Disease. Frontiers in Neuroscience. 12: 520. PMID 30123104 DOI: 10.3389/Fnins.2018.00520 |
0.453 |
|
| 2018 |
Faivre E, Coelho JE, Zornbach K, Malik E, Baqi Y, Schneider M, Cellai L, Carvalho K, Sebda S, Figeac M, Eddarkaoui S, Caillierez R, Chern Y, Heneka M, Sergeant N, et al. Beneficial Effect of a Selective Adenosine A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease. Frontiers in Molecular Neuroscience. 11: 235. PMID 30050407 DOI: 10.3389/Fnmol.2018.00235 |
0.391 |
|
| 2018 |
Chauderlier A, Gilles M, Spolcova A, Caillierez R, Chwastyniak M, Kress M, Drobecq H, Bonnefoy E, Pinet F, Weil D, Buée L, Galas MC, Lefebvre B. Tau/DDX6 interaction increases microRNA activity. Biochimica Et Biophysica Acta. PMID 29966762 DOI: 10.1016/J.Bbagrm.2018.06.006 |
0.425 |
|
| 2018 |
Temido-Ferreira M, Ferreira DG, Batalha VL, Marques-Morgado I, Coelho JE, Pereira P, Gomes R, Pinto A, Carvalho S, Canas PM, Cuvelier L, Buée-Scherrer V, Faivre E, Baqi Y, Müller CE, et al. Age-related shift in LTD is dependent on neuronal adenosine A receptors interplay with mGluR5 and NMDA receptors. Molecular Psychiatry. PMID 29950682 DOI: 10.1038/S41380-018-0110-9 |
0.341 |
|
| 2018 |
Laurent C, Buée L, Blum D. Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies? Biomedical Journal. 41: 21-33. PMID 29673549 DOI: 10.1016/J.Bj.2018.01.003 |
0.524 |
|
| 2018 |
Lee CC, Chang CP, Lin CJ, Lai HL, Kao YH, Cheng SJ, Chen HM, Liao YP, Faivre E, Buée L, Blum D, Fang JM, Chern Y. Adenosine Augmentation Evoked by an ENT1 Inhibitor Improves Memory Impairment and Neuronal Plasticity in the APP/PS1 Mouse Model of Alzheimer's Disease. Molecular Neurobiology. PMID 29616397 DOI: 10.1007/S12035-018-1030-Z |
0.398 |
|
| 2018 |
Gay M, Carato P, Coevoet M, Renault N, Larchanché PE, Barczyk A, Yous S, Buée L, Sergeant N, Melnyk P. New phenylaniline derivatives as modulators of amyloid protein precursor metabolism. Bioorganic & Medicinal Chemistry. PMID 29559198 DOI: 10.1016/J.Bmc.2018.03.016 |
0.408 |
|
| 2018 |
Marinangeli C, Kluza J, Marchetti P, Buée L, Vingtdeux V. Study of AMPK-Regulated Metabolic Fluxes in Neurons Using the Seahorse XFe Analyzer. Methods in Molecular Biology (Clifton, N.J.). 1732: 289-305. PMID 29480483 DOI: 10.1007/978-1-4939-7598-3_19 |
0.32 |
|
| 2018 |
Hanon O, Vidal JS, Lehmann S, Bombois S, Allinquant B, Tréluyer JM, Gelé P, Delmaire C, Blanc F, Mangin JF, Buée L, Touchon J, Hugon J, Vellas B, Galbrun E, et al. Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29458036 DOI: 10.1016/J.Jalz.2018.01.004 |
0.4 |
|
| 2018 |
Gratuze M, Joly-Amado A, Vieau D, Buée L, Blum D. Mutual relationship between Tau and central insulin signalling: consequences for AD and Tauopathies ? Neuroendocrinology. PMID 29439247 DOI: 10.1159/000487641 |
0.397 |
|
| 2018 |
Vercruysse O, Paquet C, Gabelle A, Delbeuck X, Blanc F, Wallon D, Dumurgier J, Magnin E, Martinaud O, Jung B, Bousiges O, Lehmann S, Delaby C, Quillard-Murain M, Peoc'h K, et al. Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF biomarkers. Current Alzheimer Research. PMID 29318973 DOI: 10.2174/1567205015666180110113238 |
0.38 |
|
| 2018 |
Houben S, Leroy K, Ando K, Yilmaz Z, Buée L, Brion JP. Lack Of Endogenous Tau Rescues Impaired Adult Neurogenesis In The Dentate Gyrus In FTLD-17 Human Mutant Tau Transgenic Mice Frontiers in Neuroscience. 12. DOI: 10.3389/Conf.Fnins.2018.95.00001 |
0.424 |
|
| 2018 |
Susloparova A, Coffinier Y, Alibart F, Thomy V, Arscott S, Pallecchi E, Begard S, Halliez S, Colin M, Buée L. Fabrication of new transparent MEAs made from pure PEDOT:PSS and their optical/electrical properties for neurons' activity assessment in the frame of Alzheimer disease case study Frontiers in Cellular Neuroscience. 12. DOI: 10.3389/Conf.Fncel.2018.38.00035 |
0.698 |
|
| 2018 |
Albert M, Caillierez R, Danis C, Lieger S, Bégard S, Mairet-Coello G, Courade J, Citron M, Buee L, Colin M. O4-05-05: Prevention Of Tau Seeding And Spreading In Transgenic Mouse Models Based On Intracranial-Injection Of P301L-K18 Fibrils Or Alzheimer'S Disease Lysate By Passive Immunotherapy Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2937 |
0.719 |
|
| 2017 |
Mudher A, Colin M, Dujardin S, Medina M, Dewachter I, Naini SMA, Mandelkow EM, Mandelkow E, Buée L, Goedert M, Brion JP. What is the evidence that tau pathology spreads through prion-like propagation? Acta Neuropathologica Communications. 5: 99. PMID 29258615 DOI: 10.1186/S40478-017-0488-7 |
0.843 |
|
| 2017 |
d'Orange M, Aurégan G, Cheramy D, Gaudin-Guérif M, Lieger S, Guillermier M, Stimmer L, Joséphine C, Hérard AS, Gaillard MC, Petit F, Kiessling MC, Schmitz C, Colin M, Buée L, et al. Potentiating tangle formation reduces acute toxicity of soluble tau species in the rat. Brain : a Journal of Neurology. PMID 29253129 DOI: 10.1093/Brain/Awx342 |
0.781 |
|
| 2017 |
Sotiropoulos I, Galas MC, Silva JM, Skoulakis E, Wegmann S, Maina MB, Blum D, Sayas CL, Mandelkow EM, Mandelkow E, Spillantini MG, Sousa N, Avila J, Medina M, Mudher A, et al. Atypical, non-standard functions of the microtubule associated Tau protein. Acta Neuropathologica Communications. 5: 91. PMID 29187252 DOI: 10.1186/S40478-017-0489-6 |
0.539 |
|
| 2017 |
Mudher A, Brion JP, Avila J, Medina M, Buée L. EuroTau: towing scientists to tau without tautology. Acta Neuropathologica Communications. 5: 90. PMID 29187238 DOI: 10.1186/S40478-017-0491-Z |
0.521 |
|
| 2017 |
Laurent C, Dorothée G, Hunot S, Martin E, Delarasse C, Buée L, Blum D. [Tau and cognitive disorders: a role for T lymphocytes]. Medecine Sciences : M/S. 33: 817-819. PMID 28994367 DOI: 10.1051/Medsci/20173310002 |
0.304 |
|
| 2017 |
Huin V, Buée L, Behal H, Labreuche J, Sablonnière B, Dhaenens CM. Alternative promoter usage generates novel shorter MAPT mRNA transcripts in Alzheimer's disease and progressive supranuclear palsy brains. Scientific Reports. 7: 12589. PMID 28974731 DOI: 10.1038/S41598-017-12955-7 |
0.365 |
|
| 2017 |
Lebouvier T, Pasquier F, Buée L. Update on tauopathies. Current Opinion in Neurology. PMID 28914736 DOI: 10.1097/Wco.0000000000000502 |
0.413 |
|
| 2017 |
Marciniak E, Leboucher A, Caron E, Ahmed T, Tailleux A, Dumont J, Issad T, Gerhardt E, Pagesy P, Vileno M, Bournonville C, Hamdane M, Bantubungi K, Lancel S, Demeyer D, et al. Tau deletion promotes brain insulin resistance. The Journal of Experimental Medicine. PMID 28652303 DOI: 10.1084/Jem.20161731 |
0.474 |
|
| 2017 |
Shelkovnikova TA, Dimasi P, Kukharsky MS, An H, Quintiero A, Schirmer C, Buée L, Galas MC, Buchman VL. Chronically stressed or stress-preconditioned neurons fail to maintain stress granule assembly. Cell Death & Disease. 8: e2788. PMID 28492545 DOI: 10.1038/Cddis.2017.199 |
0.327 |
|
| 2017 |
Vanden Dries V, Stygelbout V, Pierrot N, Yilmaz Z, Suain V, De Decker R, Buée L, Octave JN, Brion JP, Leroy K. Amyloid precursor protein reduction enhances the formation of neurofibrillary tangles in a mutant tau transgenic mouse model. Neurobiology of Aging. PMID 28464981 DOI: 10.1016/J.Neurobiolaging.2017.03.031 |
0.529 |
|
| 2017 |
Chauderlier A, Delattre L, Buée L, Galas MC. In Vivo Hyperthermic Stress Model: An Easy Tool to Study the Effects of Oxidative Stress on Neuronal Tau Functionality in Mouse Brain. Methods in Molecular Biology (Clifton, N.J.). 1523: 369-373. PMID 27975265 DOI: 10.1007/978-1-4939-6598-4_25 |
0.358 |
|
| 2017 |
Sergeant N, Fernandez-Gomez FJ, Obriot H, Eddarkaoui S, Buée-Scherrer V, Buée L. Two-Dimensional Electrophoresis Protocols to Analyze the Microtubule-Associated Tau Proteins from Several Biological Sources. Methods in Molecular Biology (Clifton, N.J.). 1523: 251-261. PMID 27975254 DOI: 10.1007/978-1-4939-6598-4_14 |
0.426 |
|
| 2017 |
Moulin S, Leys D, Schraen-Maschke S, Bombois S, Mendyk AM, Muhr-Tailleux A, Cordonnier C, Buee L, Pasquier F, Bordet R. Aβ1-40 and Aβ1-42 Plasmatic Levels In Stroke: Influence of Pre-Existing Cognitive Status and Stroke Characteristics. Current Alzheimer Research. 14: 686-694. PMID 26502812 DOI: 10.2174/1567205012666151027141730 |
0.339 |
|
| 2017 |
Colin M, Tardivel M, Bégard S, Bousset L, Dujardin S, Richetin K, Deglon N, Melki R, Buee L. Tau Spreading: How Are Tau Assemblies Transferred From Cell To Cell? Alzheimers & Dementia. 13: 906. DOI: 10.1016/J.Jalz.2017.07.320 |
0.81 |
|
| 2017 |
Anquetil V, Bertrand A, Camuzat A, Grange Pdl, Fournier C, Buée-Scherrer V, Deramecourt V, Sergeant N, Barbier M, Buee L, Brice A, Duyckaerts C, Ber IL. Frontotemporal Lobar Degenerations, Rnaopathy Leading To Proteinopathies Alzheimers & Dementia. 13: 1301. DOI: 10.1016/J.Jalz.2017.06.1982 |
0.357 |
|
| 2017 |
Garcia-Nuñez A, Malmanche N, Dourlen P, Gistelinck M, Geurs S, Reynaert M, Davoine L, Dupont C, Amouyel P, Buee L, Callaerts P, Lambert J, Voet T, Galas M, Dermaut B. [P4-089]: EXPERIMENTAL IN VIVO
EVIDENCE FOR TAU-INDUCED ANEUPLOIDY GENERATED DURING BRAIN DEVELOPMENT IN TAUOPATHIES Alzheimer's & Dementia. 13: P1292-P1293. DOI: 10.1016/J.Jalz.2017.06.1954 |
0.401 |
|
| 2016 |
Paban V, Loriod B, Villard C, Buee L, Blum D, Pietropaolo S, Cho YH, Gory-Faure S, Mansour E, Gharbi A, Alescio-Lautier B. Omics analysis of mouse brain models of human diseases. Gene. PMID 27871923 DOI: 10.1016/J.Gene.2016.11.022 |
0.348 |
|
| 2016 |
Laurent C, Dorothée G, Hunot S, Martin E, Monnet Y, Duchamp M, Dong Y, Légeron FP, Leboucher A, Burnouf S, Faivre E, Carvalho K, Caillierez R, Zommer N, Demeyer D, et al. Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy. Brain : a Journal of Neurology. PMID 27818384 DOI: 10.1093/Brain/Aww270 |
0.473 |
|
| 2016 |
Tardivel M, Bégard S, Bousset L, Dujardin S, Coens A, Melki R, Buée L, Colin M. Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological Tau protein assemblies. Acta Neuropathologica Communications. 4: 117. PMID 27809932 DOI: 10.1186/S40478-016-0386-4 |
0.829 |
|
| 2016 |
Huin V, Deramecourt V, Caparros-Lefebvre D, Maurage CA, Duyckaerts C, Kovari E, Pasquier F, Buée-Scherrer V, Labreuche J, Behal H, Buée L, Dhaenens CM, Sablonnière B. The MAPT gene is differentially methylated in the progressive supranuclear palsy brain. Movement Disorders : Official Journal of the Movement Disorder Society. 31: 1883-1890. PMID 27709663 DOI: 10.1002/Mds.26820 |
0.398 |
|
| 2016 |
Mansuroglu Z, Benhelli-Mokrani H, Marcato V, Sultan A, Violet M, Chauderlier A, Delattre L, Loyens A, Talahari S, Bégard S, Nesslany F, Colin M, Souès S, Lefebvre B, Buée L, et al. Loss of Tau protein affects the structure, transcription and repair of neuronal pericentromeric heterochromatin. Scientific Reports. 6: 33047. PMID 27605042 DOI: 10.1038/Srep33047 |
0.746 |
|
| 2016 |
Audouard E, Houben S, Masaracchia C, Yilmaz Z, Suain V, Authelet M, De Decker R, Buée L, Boom A, Leroy K, Ando K, Brion JP. High-Molecular-Weight Paired Helical Filaments from Alzheimer Brain Induces Seeding of Wild-Type Mouse Tau into an Argyrophilic 4R Tau Pathology in Vivo. The American Journal of Pathology. PMID 27497324 DOI: 10.1016/J.Ajpath.2016.06.008 |
0.55 |
|
| 2016 |
Papegaey A, Eddarkaoui S, Deramecourt V, Fernandez-Gomez FJ, Pantano P, Obriot H, Machala C, Anquetil V, Camuzat A, Brice A, Maurage CA, Le Ber I, Duyckaerts C, Buée L, Sergeant N, et al. Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation. Acta Neuropathologica Communications. 4: 74. PMID 27435172 DOI: 10.1186/S40478-016-0345-0 |
0.507 |
|
| 2016 |
Chen W, Abud EA, Yeung ST, Lakatos A, Nassi T, Wang J, Blum D, Buée L, Poon WW, Blurton-Jones M. Increased tauopathy drives microglia-mediated clearance of beta-amyloid. Acta Neuropathologica Communications. 4: 63. PMID 27339073 DOI: 10.1186/S40478-016-0336-1 |
0.487 |
|
| 2016 |
Domise M, Didier S, Marinangeli C, Zhao H, Chandakkar P, Buée L, Viollet B, Davies P, Marambaud P, Vingtdeux V. AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo. Scientific Reports. 6: 26758. PMID 27230293 DOI: 10.1038/Srep26758 |
0.535 |
|
| 2016 |
Dourlen P, Fernandez-Gomez FJ, Dupont C, Grenier-Boley B, Bellenguez C, Obriot H, Caillierez R, Sottejeau Y, Chapuis J, Bretteville A, Abdelfettah F, Delay C, Malmanche N, Soininen H, Hiltunen M, et al. Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology. Molecular Psychiatry. PMID 27113998 DOI: 10.1038/Mp.2016.59 |
0.509 |
|
| 2016 |
Šimić G, Leko MB, Wray S, Harrington C, Delalle I, Jovanov-Milošević N, Bažadona D, Buée L, Silva R, Giovanni GD, Wischik C, Hof PR. Monoaminergic Neuropathology in Alzheimer's disease. Progress in Neurobiology. PMID 27084356 DOI: 10.1016/J.Pneurobio.2016.04.001 |
0.413 |
|
| 2016 |
Barthélemy NR, Gabelle A, Hirtz C, Fenaille F, Sergeant N, Schraen-Maschke S, Vialaret J, Buée L, Junot C, Becher F, Lehmann S. Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies. Journal of Alzheimer's Disease : Jad. 51: 1033-43. PMID 26923020 DOI: 10.3233/Jad-150962 |
0.5 |
|
| 2016 |
Šimić G, Babić Leko M, Wray S, Harrington C, Delalle I, Jovanov-Milošević N, Bažadona D, Buée L, de Silva R, Di Giovanni G, Wischik C, Hof PR. Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies. Biomolecules. 6. PMID 26751493 DOI: 10.3390/biom6010006 |
0.466 |
|
| 2016 |
Barthélemy NR, Fenaille F, Hirtz C, Sergeant N, Schraen-Maschke S, Vialaret J, Buée L, Gabelle A, Junot C, Lehmann S, Becher F. Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity. Journal of Proteome Research. 15: 667-76. PMID 26742856 DOI: 10.1021/Acs.Jproteome.5B01001 |
0.435 |
|
| 2016 |
Houben S, Audouard E, Masaracchia C, Yilmaz Z, Suain V, Authelet M, Decker RD, Buée L, Boom A, Leroy K, Ando K, Brion JP. Stereotaxic injection of fibrillar PHF from Alzheimer brain induces propagation of argyrophilic grains constituted of murine tau in mouse brains Frontiers in Aging Neuroscience. 8. DOI: 10.3389/Conf.Fnagi.2016.03.00040 |
0.41 |
|
| 2016 |
Buee L, Dujardin S, Tardivel M, Begard S, Caillierez R, Bousset L, Melki R, Colin M. The ins and outs of tau propagation Neurobiology of Aging. 39. DOI: 10.1016/J.Neurobiolaging.2016.01.071 |
0.824 |
|
| 2016 |
Gary C, Koch J, Petit F, Hanss Z, Palash AR, Eddarkaoui S, Sawiak S, Herard A, Deslys J, Buee L, Comoy E, Picq J, Pifferi F, Dhenain M. First Demonstration Of Functional And Morphological Alterations In Primates After Alzheimer Brain Homogenates Inoculation Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.668 |
0.371 |
|
| 2015 |
García-Gómez BE, Fernández-Gómez FJ, Muñoz-Delgado E, Buée L, Blum D, Vidal CJ. mRNA Levels of ACh-Related Enzymes in the Hippocampus of THY-Tau22 Mouse: A Model of Human Tauopathy with No Signs of Motor Disturbance. Journal of Molecular Neuroscience : Mn. PMID 26697857 DOI: 10.1007/S12031-015-0699-Y |
0.443 |
|
| 2015 |
Violet M, Chauderlier A, Delattre L, Tardivel M, Chouala MS, Sultan A, Marciniak E, Humez S, Binder L, Kayed R, Lefebvre B, Bonnefoy E, Buée L, Galas MC. Prefibrillar Tau oligomers alter the nucleic acid protective function of Tau in hippocampal neurons in vivo. Neurobiology of Disease. 82: 540-51. PMID 26385829 DOI: 10.1016/J.Nbd.2015.09.003 |
0.499 |
|
| 2015 |
Delaby C, Gabelle A, Blum D, Schraen-Maschke S, Moulinier A, Boulanghien J, Séverac D, Buée L, Rème T, Lehmann S. Central Nervous System and Peripheral Inflammatory Processes in Alzheimer's Disease: Biomarker Profiling Approach. Frontiers in Neurology. 6: 181. PMID 26379616 DOI: 10.3389/Fneur.2015.00181 |
0.387 |
|
| 2015 |
Smith PY, Hernandez-Rapp J, Jolivette F, Lecours C, Bisht K, Goupil C, Dorval V, Parsi S, Morin F, Planel E, Bennett DA, Fernandez-Gomez FJ, Sergeant N, Buée L, Tremblay MÈ, et al. miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo. Human Molecular Genetics. PMID 26362250 DOI: 10.1093/Hmg/Ddv377 |
0.407 |
|
| 2015 |
Burlot MA, Braudeau J, Michaelsen-Preusse K, Potier B, Ayciriex S, Varin J, Gautier B, Djelti F, Audrain M, Dauphinot L, Fernandez-Gomez FJ, Caillierez R, Laprévote O, Bièche I, Auzeil N, et al. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology. Human Molecular Genetics. 24: 5965-76. PMID 26358780 DOI: 10.1093/Hmg/Ddv268 |
0.524 |
|
| 2015 |
Multhaup G, Huber O, Buée L, Galas MC. Amyloid Precursor Protein (APP) Metabolites APP Intracellular Fragment (AICD), Aβ42, and Tau in Nuclear Roles. The Journal of Biological Chemistry. 290: 23515-22. PMID 26296890 DOI: 10.1074/Jbc.R115.677211 |
0.506 |
|
| 2015 |
Kaffashian S, Tzourio C, Soumaré A, Dufouil C, Mazoyer B, Schraen-Maschke S, Buée L, Debette S. Association of plasma β-amyloid with MRI markers of structural brain aging the 3-City Dijon study. Neurobiology of Aging. 36: 2663-70. PMID 26242707 DOI: 10.1016/J.Neurobiolaging.2015.03.016 |
0.367 |
|
| 2015 |
Caillet-Boudin ML, Buée L, Sergeant N, Lefebvre B. Regulation of human MAPT gene expression. Molecular Neurodegeneration. 10: 28. PMID 26170022 DOI: 10.1186/S13024-015-0025-8 |
0.434 |
|
| 2015 |
Derisbourg M, Leghay C, Chiappetta G, Fernandez-Gomez FJ, Laurent C, Demeyer D, Carrier S, Buée-Scherrer V, Blum D, Vinh J, Sergeant N, Verdier Y, Buée L, Hamdane M. Role of the Tau N-terminal region in microtubule stabilization revealed by new endogenous truncated forms. Scientific Reports. 5: 9659. PMID 25974414 DOI: 10.1038/Srep09659 |
0.516 |
|
| 2015 |
Sigala J, Jumeau F, Buée L, Sergeant N, Mitchell V. [The testicular microtubule-associated protein Tau: Where, when during spermatogenesis?]. Morphologie : Bulletin De L'Association Des Anatomistes. 99: 141-8. PMID 25908520 DOI: 10.1016/J.Morpho.2015.03.001 |
0.437 |
|
| 2015 |
Giustiniani J, Guillemeau K, Dounane O, Sardin E, Huvent I, Schmitt A, Hamdane M, Buée L, Landrieu I, Lippens G, Baulieu EE, Chambraud B. The FK506-binding protein FKBP52 in vitro induces aggregation of truncated Tau forms with prion-like behavior. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 25888602 DOI: 10.1096/Fj.14-268243 |
0.533 |
|
| 2015 |
Duyckaerts C, Braak H, Brion JP, Buée L, Del Tredici K, Goedert M, Halliday G, Neumann M, Spillantini MG, Tolnay M, Uchihara T. PART is part of Alzheimer disease. Acta Neuropathologica. 129: 749-56. PMID 25628035 DOI: 10.1007/S00401-015-1390-7 |
0.473 |
|
| 2015 |
Qi H, Cantrelle FX, Benhelli-Mokrani H, Smet-Nocca C, Buée L, Lippens G, Bonnefoy E, Galas MC, Landrieu I. Nuclear magnetic resonance spectroscopy characterization of interaction of Tau with DNA and its regulation by phosphorylation. Biochemistry. 54: 1525-33. PMID 25623359 DOI: 10.1021/Bi5014613 |
0.454 |
|
| 2015 |
Melnyk P, Vingtdeux V, Burlet S, Eddarkaoui S, Grosjean ME, Larchanché PE, Hochart G, Sergheraert C, Estrella C, Barrier M, Poix V, Plancq P, Lannoo C, Hamdane M, Delacourte A, et al. Chloroquine and chloroquinoline derivatives as models for the design of modulators of amyloid Peptide precursor metabolism. Acs Chemical Neuroscience. 6: 559-69. PMID 25611616 DOI: 10.1021/Cn5003013 |
0.385 |
|
| 2015 |
Rosseels J, Van den Brande J, Violet M, Jacobs D, Grognet P, Lopez J, Huvent I, Caldara M, Swinnen E, Papegaey A, Caillierez R, Buée-Scherrer V, Engelborghs S, Lippens G, Colin M, et al. Tau monoclonal antibody generation based on humanized yeast models: impact on Tau oligomerization and diagnostics. The Journal of Biological Chemistry. 290: 4059-74. PMID 25540200 DOI: 10.1074/Jbc.M114.627919 |
0.769 |
|
| 2015 |
Ahmed T, Blum D, Burnouf S, Demeyer D, Buée-Scherrer V, D'Hooge R, Buée L, Balschun D. Rescue of impaired late-phase long-term depression in a tau transgenic mouse model. Neurobiology of Aging. 36: 730-9. PMID 25443285 DOI: 10.1016/J.Neurobiolaging.2014.09.015 |
0.435 |
|
| 2015 |
Martel G, Simon A, Nocera S, Kalainathan S, Pidoux L, Blum D, Leclère-Turbant S, Diaz J, Geny D, Moyse E, Videau C, Buée L, Epelbaum J, Viollet C. Aging, but not tau pathology, impacts olfactory performances and somatostatin systems in THY-Tau22 mice. Neurobiology of Aging. 36: 1013-28. PMID 25433460 DOI: 10.1016/J.Neurobiolaging.2014.10.033 |
0.403 |
|
| 2015 |
Dujardin S, Colin M, Buée L. Invited review: Animal models of tauopathies and their implications for research/translation into the clinic. Neuropathology and Applied Neurobiology. 41: 59-80. PMID 25428793 DOI: 10.1111/Nan.12200 |
0.819 |
|
| 2015 |
Frederick C, Ando K, Leroy K, Héraud C, Suain V, Buée L, Brion JP. Rapamycin ester analog CCI-779/Temsirolimus alleviates tau pathology and improves motor deficit in mutant tau transgenic mice. Journal of Alzheimer's Disease : Jad. 44: 1145-56. PMID 25408212 DOI: 10.3233/Jad-142097 |
0.42 |
|
| 2015 |
Blum D, Herrera F, Francelle L, Mendes T, Basquin M, Obriot H, Demeyer D, Sergeant N, Gerhardt E, Brouillet E, Buée L, Outeiro TF. Mutant huntingtin alters Tau phosphorylation and subcellular distribution. Human Molecular Genetics. 24: 76-85. PMID 25143394 DOI: 10.1093/Hmg/Ddu421 |
0.533 |
|
| 2015 |
Buee L, Colin M, Dujardin S, Badin RA, Bemelmans A, Jan C, Camp NV, Deglon N, Hantraye P. Non-human primate model of tauopathy Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.07.060 |
0.755 |
|
| 2014 |
Laurent C, Burnouf S, Ferry B, Batalha VL, Coelho JE, Baqi Y, Malik E, Mariciniak E, Parrot S, Van der Jeugd A, Faivre E, Flaten V, Ledent C, D'Hooge R, Sergeant N, et al. A2A adenosine receptor deletion is protective in a mouse model of Tauopathy. Molecular Psychiatry. PMID 25450226 DOI: 10.1038/Mp.2014.151 |
0.469 |
|
| 2014 |
Sigala J, Jumeau F, Caillet-Boudin ML, Sergeant N, Ballot C, Rigot JM, Marcelli F, Tardivel M, Buée L, Mitchell V. Immunodetection of Tau microtubule-associated protein in human sperm and testis. Asian Journal of Andrology. 16: 927-8. PMID 25219911 DOI: 10.4103/1008-682X.136446 |
0.413 |
|
| 2014 |
Chaalal A, Poirier R, Blum D, Gillet B, Le Blanc P, Basquin M, Buée L, Laroche S, Enderlin V. PTU-induced hypothyroidism in rats leads to several early neuropathological signs of Alzheimer's disease in the hippocampus and spatial memory impairments. Hippocampus. 24: 1381-93. PMID 24978200 DOI: 10.1002/Hipo.22319 |
0.387 |
|
| 2014 |
Dujardin S, Bégard S, Caillierez R, Lachaud C, Delattre L, Carrier S, Loyens A, Galas MC, Bousset L, Melki R, Aurégan G, Hantraye P, Brouillet E, Buée L, Colin M. Ectosomes: a new mechanism for non-exosomal secretion of tau protein. Plos One. 9: e100760. PMID 24971751 DOI: 10.1371/Journal.Pone.0100760 |
0.834 |
|
| 2014 |
Ahmed T, Van der Jeugd A, Blum D, Galas MC, D'Hooge R, Buee L, Balschun D. Cognition and hippocampal synaptic plasticity in mice with a homozygous tau deletion. Neurobiology of Aging. 35: 2474-8. PMID 24913895 DOI: 10.1016/J.Neurobiolaging.2014.05.005 |
0.411 |
|
| 2014 |
Laurent C, Eddarkaoui S, Derisbourg M, Leboucher A, Demeyer D, Carrier S, Schneider M, Hamdane M, Müller CE, Buée L, Blum D. Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology. Neurobiology of Aging. 35: 2079-90. PMID 24780254 DOI: 10.1016/J.Neurobiolaging.2014.03.027 |
0.497 |
|
| 2014 |
Fernandez-Gomez FJ, Jumeau F, Derisbourg M, Burnouf S, Tran H, Eddarkaoui S, Obriot H, Dutoit-Lefevre V, Deramecourt V, Mitchell V, Lefranc D, Hamdane M, Blum D, Buée L, Buée-Scherrer V, et al. Consensus brain-derived protein, extraction protocol for the study of human and murine brain proteome using both 2D-DIGE and mini 2DE immunoblotting. Journal of Visualized Experiments : Jove. PMID 24747743 DOI: 10.3791/51339 |
0.365 |
|
| 2014 |
Violet M, Delattre L, Tardivel M, Sultan A, Chauderlier A, Caillierez R, Talahari S, Nesslany F, Lefebvre B, Bonnefoy E, Buée L, Galas MC. A major role for Tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions. Frontiers in Cellular Neuroscience. 8: 84. PMID 24672431 DOI: 10.3389/Fncel.2014.00084 |
0.441 |
|
| 2014 |
Flaten V, Laurent C, Coelho JE, Sandau U, Batalha VL, Burnouf S, Hamdane M, Humez S, Boison D, Lopes LV, Buée L, Blum D. From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease? Biochemical Society Transactions. 42: 587-92. PMID 24646282 DOI: 10.1042/Bst20130229 |
0.416 |
|
| 2014 |
Chouraki V, De Bruijn RF, Chapuis J, Bis JC, Reitz C, Schraen S, Ibrahim-Verbaas CA, Grenier-Boley B, Delay C, Rogers R, Demiautte F, Mounier A, Fitzpatrick AL, Berr C, et al. A genome-wide association meta-analysis of plasma Aβ peptides concentrations in the elderly. Molecular Psychiatry. 19: 1326-35. PMID 24535457 DOI: 10.1038/Mp.2013.185 |
0.373 |
|
| 2014 |
Dujardin S, Lécolle K, Caillierez R, Bégard S, Zommer N, Lachaud C, Carrier S, Dufour N, Aurégan G, Winderickx J, Hantraye P, Déglon N, Colin M, Buée L. Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies. Acta Neuropathologica Communications. 2: 14. PMID 24479894 DOI: 10.1186/2051-5960-2-14 |
0.844 |
|
| 2014 |
Carpentier C, Ghanem D, Fernandez-Gomez FJ, Jumeau F, Philippe JV, Freyermuth F, Labudeck A, Eddarkaoui S, Dhaenens CM, Holt I, Behm-Ansmant I, Marmier-Gourrier N, Branlant C, Charlet-Berguerand N, Marie J, et al. Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2. Biochimica Et Biophysica Acta. 1842: 654-64. PMID 24440524 DOI: 10.1016/J.Bbadis.2014.01.004 |
0.466 |
|
| 2014 |
Caillet-Boudin ML, Fernandez-Gomez FJ, Tran H, Dhaenens CM, Buee L, Sergeant N. Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy. Frontiers in Molecular Neuroscience. 6: 57. PMID 24409116 DOI: 10.3389/Fnmol.2013.00057 |
0.445 |
|
| 2014 |
Dujardin S, Brouillet E, Hantraye P, Colin M, Buée L. Which Tau species are toxic? Consequences for therapeutic approaches Neurobiology of Aging. 35: S4. DOI: 10.1016/J.Neurobiolaging.2014.01.042 |
0.795 |
|
| 2014 |
Pires CA, Zommer N, Caillierez R, Arnaud C, Pepin J-, Buee L, Charley CM. Stress hypoxique intermittent, atteinte mnésique et protéine Tau : évaluations in vivo Neurophysiologie Clinique-Clinical Neurophysiology. 11: 7. DOI: 10.1016/J.Msom.2014.01.014 |
0.343 |
|
| 2014 |
Delaby C, Gabelle A, Blum D, Schraen-Maschke S, Boulanghien J, Rème T, Buée L, Lehmann S. Peripheral Inflammatory Processes In Alzheimer Disease: Biomarkers Profiling Approach Alzheimers & Dementia. 10: 335. DOI: 10.1016/J.Jalz.2014.05.327 |
0.337 |
|
| 2014 |
Braudeau J, Burlot M, Ayciriex S, Varin J, Gautier B, Djelti F, Dauphinot L, Nadege Z, Caillierez R, Pradier L, Laprevote O, Bieche I, Auzeil N, Potier M, Aubourg P, et al. Cholesterol And Tau Pathology: Consequences Of Aav-Mediated Cholesterol-24-Hydroxylase Overexpression In The Thy-Tau22 Mouse Alzheimers & Dementia. 10: 237. DOI: 10.1016/J.Jalz.2014.04.349 |
0.427 |
|
| 2014 |
Barthelemy N, Lehmann S, Hirtz C, Gabelle A, Sergeant N, Fenaille F, Vialaret J, Schraen S, Bros P, Tiers L, Delaby C, Junot C, Touchon J, Buee L, Becher F. Detection And Quantification Of The Tau Protein And Its Isoforms In The Csf Of Alzheimer'S Disease Patients Using Mass Spectrometry Alzheimers & Dementia. 10: 147. DOI: 10.1016/J.Jalz.2014.04.105 |
0.406 |
|
| 2013 |
Chaunu MP, Deramecourt V, Buée-Scherrer V, Le Ber I, Brice A, Ehrle N, El Hachimi K, Pluot M, Maurage CA, Bakchine S, Buée L. Juvenile frontotemporal dementia with parkinsonism associated with tau mutation G389R. Journal of Alzheimer's Disease : Jad. 37: 769-76. PMID 23948919 DOI: 10.3233/Jad-130413 |
0.405 |
|
| 2013 |
Van der Jeugd A, Vermaercke B, Derisbourg M, Lo AC, Hamdane M, Blum D, Buée L, D'Hooge R. Progressive age-related cognitive decline in tau mice. Journal of Alzheimer's Disease : Jad. 37: 777-88. PMID 23948912 DOI: 10.3233/Jad-130110 |
0.421 |
|
| 2013 |
Lo AC, Iscru E, Blum D, Tesseur I, Callaerts-Vegh Z, Buée L, De Strooper B, Balschun D, D'Hooge R. Amyloid and tau neuropathology differentially affect prefrontal synaptic plasticity and cognitive performance in mouse models of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 37: 109-25. PMID 23788007 DOI: 10.3233/Jad-122296 |
0.484 |
|
| 2013 |
Simonin C, Duru C, Salleron J, Hincker P, Charles P, Delval A, Youssov K, Burnouf S, Azulay JP, Verny C, Scherer C, Tranchant C, Goizet C, Debruxelles S, Defebvre L, et al. Association between caffeine intake and age at onset in Huntington's disease. Neurobiology of Disease. 58: 179-82. PMID 23732677 DOI: 10.1016/J.Nbd.2013.05.013 |
0.302 |
|
| 2013 |
Blum D, Buée L. Alzheimer's disease risk, obesity and tau: is insulin resistance guilty? Expert Review of Neurotherapeutics. 13: 461-3. PMID 23621301 DOI: 10.1586/Ern.13.35 |
0.336 |
|
| 2013 |
Caillierez R, Bégard S, Lécolle K, Deramecourt V, Zommer N, Dujardin S, Loyens A, Dufour N, Aurégan G, Winderickx J, Hantraye P, Déglon N, Buée L, Colin M. Lentiviral delivery of the human wild-type tau protein mediates a slow and progressive neurodegenerative tau pathology in the rat brain. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1358-68. PMID 23609018 DOI: 10.1038/Mt.2013.66 |
0.842 |
|
| 2013 |
Leboucher A, Laurent C, Fernandez-Gomez FJ, Burnouf S, Troquier L, Eddarkaoui S, Demeyer D, Caillierez R, Zommer N, Vallez E, Bantubungi K, Breton C, Pigny P, Buée-Scherrer V, Staels B, et al. Detrimental effects of diet-induced obesity on τ pathology are independent of insulin resistance in τ transgenic mice. Diabetes. 62: 1681-8. PMID 23250356 DOI: 10.2337/Db12-0866 |
0.321 |
|
| 2013 |
Van der Jeugd A, Blum D, Raison S, Eddarkaoui S, Buée L, D'Hooge R. Observations in THY-Tau22 mice that resemble behavioral and psychological signs and symptoms of dementia. Behavioural Brain Research. 242: 34-9. PMID 23247080 DOI: 10.1016/J.Bbr.2012.12.008 |
0.434 |
|
| 2013 |
Burnouf S, Martire A, Derisbourg M, Laurent C, Belarbi K, Leboucher A, Fernandez-Gomez FJ, Troquier L, Eddarkaoui S, Grosjean ME, Demeyer D, Muhr-Tailleux A, Buisson A, Sergeant N, Hamdane M, et al. NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model. Aging Cell. 12: 11-23. PMID 23082852 DOI: 10.1111/Acel.12018 |
0.429 |
|
| 2013 |
Bombois S, Duhamel A, Salleron J, Deramecourt V, Mackowiak MA, Deken V, Sergeant N, Pasquier F, Buée L, Sablonniére B, Schraen-Maschke S. A new decision tree combining Abeta 1-42 and p-Tau levels in Alzheimer's diagnosis. Current Alzheimer Research. 10: 357-64. PMID 23061918 DOI: 10.2174/1567205011310040002 |
0.473 |
|
| 2013 |
Gabelle A, Richard F, Gutierrez LA, Schraen S, Delva F, Rouaud O, Buée L, Dartigues JF, Touchon J, Lambert JC, Berr C. Plasma amyloid-β levels and prognosis in incident dementia cases of the 3-city study Journal of Alzheimer's Disease. 33: 381-391. PMID 22976074 DOI: 10.3233/Jad-2012-121147 |
0.361 |
|
| 2013 |
Ando K, Dourlen P, Sambo AV, Bretteville A, Bélarbi K, Vingtdeux V, Eddarkaoui S, Drobecq H, Ghestem A, Bégard S, Demey-Thomas E, Melnyk P, Smet C, Lippens G, Maurage CA, et al. Tau pathology modulates Pin1 post-translational modifications and may be relevant as biomarker. Neurobiology of Aging. 34: 757-69. PMID 22926167 DOI: 10.1016/J.Neurobiolaging.2012.08.004 |
0.531 |
|
| 2013 |
Lambert JC, Grenier-Boley B, Harold D, Zelenika D, Chouraki V, Kamatani Y, Sleegers K, Ikram MA, Hiltunen M, Reitz C, Mateo I, Feulner T, Bullido M, Galimberti D, Concari L, et al. Erratum: Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease (Molecular Psychiatry (2013) 18 (521) DOI: 10.1038/mp.2012.75)) Molecular Psychiatry. 18. DOI: 10.1038/Mp.2012.75 |
0.317 |
|
| 2013 |
Buee-Scherrer V, Papegaey A, Deramecourt V, Lecourtois M, Lebert F, Campion D, Pasquier F, Sergeant N, Buee L. Frontotemporal lobar degeneration: Any link between tau and TDP-43? Alzheimers & Dementia. 9: 438. DOI: 10.1016/J.Jalz.2013.05.867 |
0.524 |
|
| 2013 |
Buee L, Dujardin S, Bégard S, Raphaëlle C, Lécolle K, Dufour N, Auregan G, Winderickx J, Philippe H, Deglon N, Colin M. In vivo tau spreading relies on the transsynaptic transfer of soluble wild-type tau species Alzheimers & Dementia. 9: 142. DOI: 10.1016/J.Jalz.2013.04.090 |
0.815 |
|
| 2012 |
Vingtdeux V, Sergeant N, Buée L. Potential contribution of exosomes to the prion-like propagation of lesions in Alzheimer's disease. Frontiers in Physiology. 3: 229. PMID 22783199 DOI: 10.3389/Fphys.2012.00229 |
0.447 |
|
| 2012 |
Hébert SS, Sergeant N, Buée L. MicroRNAs and the Regulation of Tau Metabolism. International Journal of Alzheimer's Disease. 2012: 406561. PMID 22720189 DOI: 10.1155/2012/406561 |
0.429 |
|
| 2012 |
Deramecourt V, Lebert F, Maurage CA, Fernandez-Gomez FJ, Dujardin S, Colin M, Sergeant N, Buée-Scherrer V, Clot F, Ber IL, Brice A, Pasquier F, Buée L. Clinical, neuropathological, and biochemical characterization of the novel tau mutation P332S. Journal of Alzheimer's Disease : Jad. 31: 741-9. PMID 22699846 DOI: 10.3233/Jad-2012-120160 |
0.8 |
|
| 2012 |
Brouillette J, Caillierez R, Zommer N, Alves-Pires C, Benilova I, Blum D, De Strooper B, Buée L. Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-β1-42 oligomers are revealed in vivo by using a novel animal model. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 7852-61. PMID 22674261 DOI: 10.1523/Jneurosci.5901-11.2012 |
0.412 |
|
| 2012 |
Le Freche H, Brouillette J, Fernandez-Gomez FJ, Patin P, Caillierez R, Zommer N, Sergeant N, Buée-Scherrer V, Lebuffe G, Blum D, Buée L. Tau phosphorylation and sevoflurane anesthesia: an association to postoperative cognitive impairment. Anesthesiology. 116: 779-87. PMID 22343471 DOI: 10.1097/Aln.0B013E31824Be8C7 |
0.352 |
|
| 2012 |
Troquier L, Caillierez R, Burnouf S, Fernandez-Gomez FJ, Grosjean ME, Zommer N, Sergeant N, Schraen-Maschke S, Blum D, Buee L. Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach. Current Alzheimer Research. 9: 397-405. PMID 22272619 DOI: 10.2174/156720512800492503 |
0.533 |
|
| 2012 |
Burnouf S, Belarbi K, Troquier L, Derisbourg M, Demeyer D, Leboucher A, Laurent C, Hamdane M, Buee L, Blum D. Hippocampal BDNF expression in a tau transgenic mouse model. Current Alzheimer Research. 9: 406-10. PMID 22272617 DOI: 10.2174/156720512800492468 |
0.499 |
|
| 2012 |
Freche HL, Brouillette J, Fernandez-Gomez F, Patin P, Caillierez R, Zommer N, Sergeant N, Buée-Scherrer V, Lebuffe G, Blum D, Buée L. Tau Phosphorylation and Sevoflurane Anesthesia: An Association to Postoperative Cognitive Impairment Survey of Anesthesiology. 56: 176. DOI: 10.1097/Sa.0B013E31825C1F11 |
0.352 |
|
| 2012 |
Buee L, Blum D. 10 Innovative therapeutic strategies for tau pathology: from cholesterol metabolism to immunotherapy Neurobiology of Aging. 33. DOI: 10.1016/J.Neurobiolaging.2012.01.028 |
0.377 |
|
| 2011 |
Féart C, Helmer C, Fleury H, Béjot Y, Ritchie K, Amouyel P, Schraen-Maschke S, Buée L, Lambert JC, Letenneur L, Dartigues JF. Association between IgM anti-herpes simplex virus and plasma amyloid-beta levels. Plos One. 6: e29480. PMID 22216291 DOI: 10.1371/Journal.Pone.0029480 |
0.349 |
|
| 2011 |
Deleersnijder A, Van Rompuy AS, Desender L, Pottel H, Buée L, Debyser Z, Baekelandt V, Gerard M. Comparative analysis of different peptidyl-prolyl isomerases reveals FK506-binding protein 12 as the most potent enhancer of alpha-synuclein aggregation. The Journal of Biological Chemistry. 286: 26687-701. PMID 21652707 DOI: 10.1074/Jbc.M110.182303 |
0.36 |
|
| 2011 |
Belarbi K, Burnouf S, Fernandez-Gomez FJ, Desmercières J, Troquier L, Brouillette J, Tsambou L, Grosjean ME, Caillierez R, Demeyer D, Hamdane M, Schindowski K, Blum D, Buée L. Loss of medial septum cholinergic neurons in THY-Tau22 mouse model: what links with tau pathology? Current Alzheimer Research. 8: 633-8. PMID 21605043 DOI: 10.2174/156720511796717230 |
0.526 |
|
| 2011 |
Belarbi K, Burnouf S, Fernandez-Gomez FJ, Laurent C, Lestavel S, Figeac M, Sultan A, Troquier L, Leboucher A, Caillierez R, Grosjean ME, Demeyer D, Obriot H, Brion I, Barbot B, et al. Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology. Neurobiology of Disease. 43: 486-94. PMID 21569847 DOI: 10.1016/J.Nbd.2011.04.022 |
0.461 |
|
| 2011 |
Dhaenens CM, Tran H, Frandemiche M-, Carpentier C, Schraen-Maschke S, Sistiaga A, Goicoechea M, Eddarkaoui S, Brussels Ev, Obriot H, Labudeck A, Gevaert MH, Fernandez-Gomez F, Charlet-Berguerand N, Deramecourt V, et al. Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing Biochimica Et Biophysica Acta. 1812: 732-742. PMID 21439371 DOI: 10.1016/J.Bbadis.2011.03.010 |
0.354 |
|
| 2011 |
Van der Jeugd A, Ahmed T, Burnouf S, Belarbi K, Hamdame M, Grosjean ME, Humez S, Balschun D, Blum D, Buée L, D'Hooge R. Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission. Neurobiology of Learning and Memory. 95: 296-304. PMID 21167950 DOI: 10.1016/J.Nlm.2010.12.005 |
0.423 |
|
| 2011 |
Sultan A, Nesslany F, Violet M, Bégard S, Loyens A, Talahari S, Mansuroglu Z, Marzin D, Sergeant N, Humez S, Colin M, Bonnefoy E, Buée L, Galas MC. Nuclear tau, a key player in neuronal DNA protection. The Journal of Biological Chemistry. 286: 4566-75. PMID 21131359 DOI: 10.1074/Jbc.M110.199976 |
0.744 |
|
| 2011 |
Smith P, Delay C, Planel E, Sergeant N, Buee L, Hebert S. MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.09.014 |
0.417 |
|
| 2011 |
Merlin B, Bombois S, Deramecourt V, Buee L, Pasquier F, Sablonniere B, Richard F, Schraen S. CSF biomarkers and cognitive decline in Alzheimer's disease patients Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.948 |
0.338 |
|
| 2011 |
Freche HL, Buee L, Caillierez R, Zommer N, Blum D, Troquier L, Brouillette J, Lebuffe G. Tau phosphorylation and anaesthesia: A link to postoperative cognitive impairment Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.322 |
0.354 |
|
| 2011 |
Lécolle K, Buee L, Colin M, Bégard S, Caillierez R, Zommer N, Blum D, Hantraye P, Deglon N. Lentiviral delivery of human wild-type Tau protein mediates a slow and progressive spatio-temporal Tau pathology in rat brain Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.321 |
0.746 |
|
| 2011 |
Buee L. From tau biology to tauopathy: Toward new therapeutic strategies Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1941 |
0.427 |
|
| 2011 |
Cartier N, Gautier B, Burlot M, Troquier L, Pradier L, Aubourg P, Blum D, Buee L. AAV gene therapy with cholesterol 24-hydroxylase improves Alzheimer's phenotype of tau mouse model Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1869 |
0.384 |
|
| 2011 |
Caillet-Boudin M, Dhaenens C, Frandemiche M, Tran H, Carpentier C, Fernandez-Gomez F, Sistiaga A, Goicoechea M, Brussel EV, Obriot H, Eddarkaoui S, Gavaert M, Sablonniere B, Lopez-de-munain A, Buee L, et al. Mis-splicing of Tau Exon 2 and Exon 10 in myotonic dystrophy brain would result from different mechanisms Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1561 |
0.398 |
|
| 2011 |
Buée-Scherrer V, Burnouf S, Belarbi K, Fernandez-Gomez F, Laurent C, Troquier L, Leboucher A, Caillierez R, Sergeant N, Hamdane M, Buée L, Blum D. Voluntary exercise in THY-Tau22 mice prevents tau pathology and its consequences Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1443 |
0.414 |
|
| 2011 |
Sultan A, Nesslany F, Violet M, Loyens A, Talahari S, Mansuroglu Z, Marzin D, Sergeant N, Humez S, Colin M, Bonnefoy E, Buée L, Galas M. Nuclear tau protects DNA in stress condition Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1416 |
0.671 |
|
| 2011 |
Troquier L, Caillierez R, Burnouf S, Kervoaze G, Grosjean ME, Nadege Z, Sergeant N, Lassalle P, Blum D, Buee L. Targeting phospho-Ser422 by active Tau immunotherapy in THY-Tau22, a suitable therapeutic approach Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1402 |
0.449 |
|
| 2011 |
Letronne F, Laumet G, Demiautte F, Colin M, Ayral A, Hot D, Hansmannel F, Mounier A, Berr C, Huot L, Checler F, Pasquier F, Hauw J, Lemoine Y, Buee L, et al. Characterization of a new ADAM as a key player of the APP metabolism Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1125 |
0.652 |
|
| 2011 |
Hansmannel F, Mounier A, Gistelinck M, Grenier-Boley B, Maturski ME, Letronne F, Ayral A, Checler F, Buée L, Amouyel P, Dermaut B, Lambert J. Assessment of BIN1 involvement in the Alzheimer's Disease pathophysiological process Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1117 |
0.373 |
|
| 2010 |
Buée L, Blum D, Bombois S, Buée-Scherrer V, Caillet-Boudin ML, Colin M, Deramecourt V, Dhaenens CM, Galas MC, Hamdane M, Humez S, Maurage CA, Pasquier F, Sablonnière B, Schraen-Maschke S, et al. [Molecular actors in Alzheimer's disease: which diagnostic and therapeutic consequences?]. ThéRapie. 65: 401-7. PMID 21144474 DOI: 10.2515/Therapie/2010054 |
0.656 |
|
| 2010 |
Spitzer P, Klafki HW, Blennow K, Buée L, Esselmann H, Herruka SK, Jimenez C, Klivenyi P, Lewczuk P, Maler JM, Markus K, Meyer HE, Morris C, Müller T, Otto M, et al. cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases. International Journal of Alzheimer's Disease. 2010. PMID 20886057 DOI: 10.4061/2010/548145 |
0.336 |
|
| 2010 |
Landrieu I, Leroy A, Smet-Nocca C, Huvent I, Amniai L, Hamdane M, Sibille N, Buée L, Wieruszeski JM, Lippens G. NMR spectroscopy of the neuronal tau protein: normal function and implication in Alzheimer's disease. Biochemical Society Transactions. 38: 1006-11. PMID 20658994 DOI: 10.1042/Bst0381006 |
0.478 |
|
| 2010 |
Buée L, Troquier L, Burnouf S, Belarbi K, Van der Jeugd A, Ahmed T, Fernandez-Gomez F, Caillierez R, Grosjean ME, Begard S, Barbot B, Demeyer D, Obriot H, Brion I, Buée-Scherrer V, et al. From tau phosphorylation to tau aggregation: what about neuronal death? Biochemical Society Transactions. 38: 967-72. PMID 20658986 DOI: 10.1042/Bst0380967 |
0.495 |
|
| 2010 |
Feuillette S, Deramecourt V, Laquerriere A, Duyckaerts C, Delisle MB, Maurage CA, Blum D, Buée L, Frébourg T, Campion D, Lecourtois M. Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 brains. Brain Research. 1345: 182-9. PMID 20460118 DOI: 10.1016/J.Brainres.2010.05.007 |
0.566 |
|
| 2010 |
Petzold A, Chapman MD, Schraen S, Verwey NA, Pasquier F, Bombois S, Brettschneider J, Fox NC, von Arnim CA, Teunissen C, Pijnenburg Y, Riepe MW, Otto M, Tumani H, Scheltens P, et al. An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels. Experimental Neurology. 223: 432-8. PMID 20005225 DOI: 10.1016/J.Expneurol.2009.11.010 |
0.406 |
|
| 2010 |
Deramecourt V, Lebert F, Debachy B, Mackowiak-Cordoliani MA, Bombois S, Kerdraon O, Buée L, Maurage CA, Pasquier F. Prediction of pathology in primary progressive language and speech disorders. Neurology. 74: 42-49. PMID 19940270 DOI: 10.1212/Wnl.0B013E3181C7198E |
0.38 |
|
| 2010 |
Buée L, Burnouf S, Troquier L, Leboucher A, Laurent C, Freche HL, Brouillette J, Hamdane M, Sergeant N, Blum D. S.02.04 Physiopathological features of tauopathies and tau transgenic mice European Neuropsychopharmacology. 20. DOI: 10.1016/S0924-977X(10)70123-1 |
0.374 |
|
| 2010 |
Bombois S, Caillaux V, Delbeuck X, Schraen S, Buee L, Delmaire C, Pasquier F. Pattern of Brain Atrophy in MCI Patients With Csf Biomarkers Titration Suggestive of Cerebral Alzheimer's Disease Pathologic Changes Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.08.193 |
0.397 |
|
| 2010 |
Buee L. BDNF-mediated synaptic facilitation in the hippocampus is impaired in the Thy-Tau22 transgenic tau model Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.458 |
0.452 |
|
| 2009 |
Lambert JC, Schraen-Maschke S, Richard F, Fievet N, Rouaud O, Berr C, Dartigues JF, Tzourio C, Alpérovitch A, Buée L, Amouyel P. Association of plasma amyloid β with risk of dementia The prospective Three-City Study Neurology. 73: 847-853. PMID 19752451 DOI: 10.1212/Wnl.0B013E3181B78448 |
0.384 |
|
| 2009 |
Belarbi K, Schindowski K, Burnouf S, Caillierez R, Grosjean ME, Demeyer D, Hamdane M, Sergeant N, Blum D, Buée L. Early Tau pathology involving the septo-hippocampal pathway in a Tau transgenic model: relevance to Alzheimer's disease. Current Alzheimer Research. 6: 152-7. PMID 19355850 DOI: 10.2174/156720509787602843 |
0.552 |
|
| 2009 |
Ghanem D, Tran H, Dhaenens C, Schraen-Maschke S, Sablonnière B, Buée L, Sergeant N, Caillet-Boudin M. Altered splicing of Tau in DM1 is different from the foetal splicing process. Febs Letters. 583: 675-679. PMID 19166838 DOI: 10.1016/J.Febslet.2008.12.065 |
0.486 |
|
| 2009 |
Schraen-Maschke S, Bombois S, Vercruysse O, Ravasi L, Pasquier F, Sablonnière B, Buée L. P2a-13 Biomarqueurs Tau, p-Tau et Aβ 1-42 dans le LCR : Proposition d’arbres décisionnels pour l’aide au diagnostic des démences et de la MA Revue Neurologique. 165: 71-72. DOI: 10.1016/S0035-3787(09)72641-4 |
0.323 |
|
| 2009 |
Troquier L, Caillierez R, Kervoaze G, Grosjean M-, Brion I, Barbot B, Maurage C-, Blum D, Hamdane M, Lassalle P, Sergeant N, Buée L. P1-21 Mécanismes sous jacents à l’immunothérapie anti-Tau dans la maladie d’Alzheimer Revue Neurologique. 165: 63. DOI: 10.1016/S0035-3787(09)72626-8 |
0.362 |
|
| 2009 |
Troquier L, Burnouf S, Belarbi K, Fernandez-Gomez F, Sultan A, Grosjean M-, Demeyer D, Obriot H, Caillierez R, Galas M-, Brion I, Barbot B, Humez S, Sergeant N, Hamdane M, et al. P1-20 Effets de l’exercice volontaire à long terme dans un modèle de souris transgénique THY-Tau22 développant une pathologie Tau similaire à celle observée dans la maladie d’Alzheimer Revue Neurologique. 165: 62-63. DOI: 10.1016/S0035-3787(09)72625-6 |
0.346 |
|
| 2009 |
Tran H, Dhaenens C-, Trollet C, Obriot H, Ghanem D, Hammer C, Vanbrussels E, Charlet N, Gourdon G, Furling D, Buée L, Caillet-Boudin M-, Schraen-Maschke S, Sergeant N. P1-19 Dérégulation de l’épissage de Tau par MBNL1 dans une Tauopathie Revue Neurologique. 165: 62. DOI: 10.1016/S0035-3787(09)72624-4 |
0.33 |
|
| 2009 |
Sultan A, Nesslany F, Marzin D, Talahari S, Loyens A, Mansuroglu Z, Bonnefoy E, Buée L, Galas M-. P1-18 Protéine Tau, bien plus qu’une protéine associée aux microtubules Revue Neurologique. 165: 61-62. DOI: 10.1016/S0035-3787(09)72623-2 |
0.362 |
|
| 2009 |
Hamdane M, Desmercières J, Burnouf S, Bouafia H, Belarbi K, Troquier L, Becque S, Demeyer D, Grosjean M-, Caillierez R, Barbot B, Brion I, Gomez FF, Humez S, Sergeant N, et al. C10 Modèles expérimentaux de la pathologie Tau Revue Neurologique. 165: 23-24. DOI: 10.1016/S0035-3787(09)72563-9 |
0.349 |
|
| 2008 |
Schraen-Maschke S, Sergeant N, Dhaenens C, Bombois S, Deramecourt V, Caillet-Boudin M, Pasquier F, Maurage C, Sablonniere B, Vanmechelen E, Buee L. Tau as a biomarker of neurodegenerative diseases. Biomarkers in Medicine. 2: 363-384. PMID 20477391 DOI: 10.2217/17520363.2.4.363 |
0.504 |
|
| 2008 |
Sergeant N, Bretteville A, Hamdane M, Caillet-Boudin ML, Grognet P, Bombois S, Blum D, Delacourte A, Pasquier F, Vanmechelen E, Schraen-Maschke S, Buée L. Biochemistry of Tau in Alzheimer's disease and related neurological disorders. Expert Review of Proteomics. 5: 207-24. PMID 18466052 DOI: 10.1586/14789450.5.2.207 |
0.511 |
|
| 2008 |
Schindowski K, Belarbi K, Bretteville A, Ando K, Buée L. Neurogenesis and cell cycle-reactivated neuronal death during pathogenic tau aggregation Genes, Brain and Behavior. 7: 92-100. PMID 18184373 DOI: 10.1111/J.1601-183X.2007.00377.X |
0.534 |
|
| 2008 |
Schindowski K, Belarbi K, Buée L. Neurotrophic factors in Alzheimer's disease: role of axonal transport. Genes, Brain and Behavior. 7: 43-56. PMID 18184369 DOI: 10.1111/J.1601-183X.2007.00378.X |
0.426 |
|
| 2008 |
Brion JP, Leroy K, Ando K, Bretteville A, Yilmaz Z, Authelet M, Dedecker R, Buée L. O4-01-07: Subacute per OS lithium treatment decreases Tau phosphorylation and neurofibrillary tangles load in G272V/P301S mutant Tau transgenic mice Alzheimers & Dementia. 4: 185. DOI: 10.1016/J.Jalz.2008.05.506 |
0.414 |
|
| 2008 |
Buee L, Belarbi K, Schindowski K, Burnouf S, Grosjean M, Maurage C, Blum D, Sergeant N, Hamdane M. O1-06-06: Tau pathology triggers cell cycle reactivation, neurotrophins imbalance and cholinergic neurodegeneration Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.261 |
0.391 |
|
| 2008 |
Galas M, Dourlen P, Ando K, Bégard S, Hamdane M, Buée L. P3-313: Pin1 deregulation in Alzheimer's disease: A role in the aberrant cell cycle re-entry? Alzheimer's & Dementia. 4: T613-T613. DOI: 10.1016/J.Jalz.2008.05.1882 |
0.36 |
|
| 2008 |
Deramecourt V, Bombois S, Mackowiak M, Delacourte A, Buee L, Maurage C, Lebert F, Pasquier F. P3-008: Associated cerebral lesions in Alzheimer's disease generate clinical diagnosis difficulties: An autopsy study Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1571 |
0.318 |
|
| 2007 |
Hamdane M, Buée L. The complex p25/Cdk5 kinase in neurofibrillary degeneration and neuronal death: the missing link to cell cycle. Biotechnology Journal. 2: 967-77. PMID 17571276 DOI: 10.1002/Biot.200700059 |
0.372 |
|
| 2006 |
Landrieu I, Smet C, Wieruszeski J, Sambo A, Wintjens R, Buée L, Lippens G. Exploring the Molecular Function of PIN1 by Nuclear Magnetic Resonance Current Protein & Peptide Science. 7: 179-194. PMID 16787258 DOI: 10.2174/138920306777452303 |
0.325 |
|
| 2006 |
Galas MC, Dourlen P, Bégard S, Ando K, Blum D, Hamdane M, Buée L. The peptidylprolyl cis/trans-isomerase Pin1 modulates stress-induced dephosphorylation of Tau in neurons. Implication in a pathological mechanism related to Alzheimer disease. The Journal of Biological Chemistry. 281: 19296-304. PMID 16675464 DOI: 10.1074/Jbc.M601849200 |
0.489 |
|
| 2006 |
Lippens G, Sillen A, Smet C, Wieruszeski J, Leroy A, Buee L, Landrieu I. Studying the natively unfolded neuronal Tau protein by solution NMR spectroscopy. Protein and Peptide Letters. 13: 235-246. PMID 16515451 DOI: 10.2174/092986606775338461 |
0.427 |
|
| 2006 |
Schraen-Maschke S, Crinquette C, Bombois S, Delacourte A, Buee L, Sablonniere B, Pasquier F. P2-133: Determination of tau, phospho-tau and Abeta1-42 levels in cerebrospinal fluid of patients as a help for the early diagnosis of AD: The french experience in lille Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.971 |
0.438 |
|
| 2006 |
Schindowski K, Bretteville A, Leroy K, Begard S, Brion J, Hamdane M, Buee L. P1-062: Alzheimer’s disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.437 |
0.406 |
|
| 2006 |
Leroy K, Authelet M, Schindowski K, Bretteville A, Dedecker R, Zehra Y, Gilissen E, Begard S, Hamdane M, Boom A, Buee L, Brion J. P1-049: Alzheimer-type neurofibrillary lesions and neurofilamentous inclusions are cell-type specific in transgenic mice expressing mutated tau proteins G272V/P301S Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.424 |
0.376 |
|
| 2006 |
Buee L, Bretteville A, Ando K, Dourlen P, Kerdraon O, Begard S, Schindowski K, Maurage C, Galas M, Hamdane M. S3-03-06: Tau phosphorylation, tauopathies, mitosis-related disease Alzheimer's & Dementia. 2: S49-S50. DOI: 10.1016/J.Jalz.2006.05.2336 |
0.454 |
|
| 2006 |
Galas M, Dourlen P, Bégard S, Ando K, Hamdane M, Buée L. P3-334: Pin1 modulates oxidative stress-induced dephosphorylation of tau in neurons: Implication of the peptidyl prolyl cis/trans isomerase in a pathological mechanism related to Alzheimer's disease Alzheimer's & Dementia. 2: S473-S473. DOI: 10.1016/J.Jalz.2006.05.1604 |
0.423 |
|
| 2006 |
Vanmechelen E, Vandecasteele L, Grognet P, Catry C, Ghestem A, Gompel M, Decraemer H, Callebaut P, Kerschaver EV, Vanderstichele H, Sergeant N, Buee L, Kostanjevecki V, Blennow K, Delacourte A. P3-090: Potential diagnostic relevance of amino-terminally truncated beta-amyloid species in sporadic Alzheimer’s disease: A prospective brain study Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1357 |
0.35 |
|
| 2005 |
Smet C, Wieruszeski J, Buée L, Landrieu I, Lippens G. Regulation of Pin1 peptidyl-prolyl cis/trans isomerase activity by its WW binding module on a multi-phosphorylated peptide of Tau protein Febs Letters. 579: 4159-4164. PMID 16024016 DOI: 10.1016/J.Febslet.2005.06.048 |
0.314 |
|
| 2005 |
Vingtdeux V, Hamdane M, Gompel M, Bégard S, Drobecq H, Ghestem A, Grosjean ME, Kostanjevecki V, Grognet P, Vanmechelen E, Buée L, Delacourte A, Sergeant N. Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism. Neurobiology of Disease. 20: 625-37. PMID 15936948 DOI: 10.1016/J.Nbd.2005.05.004 |
0.384 |
|
| 2005 |
Galas M, Dourlen P, Bégard S, Vandesquille M, Hamdame M, Buée L. P1-10 The prolyl isomerase PIN1 modulates oxydative stress-induced dephosphorylation of tau in neurons Revue Neurologique. 161: 87-88. DOI: 10.1016/S0035-3787(05)85326-3 |
0.372 |
|
| 2004 |
Smet C, Sambo A, Wieruszeski J, Leroy A, Landrieu I, Buée L, Lippens G. The peptidyl prolyl cis/trans-isomerase Pin1 recognizes the phospho-Thr212-Pro213 site on Tau. Biochemistry. 43: 2032-2040. PMID 14967043 DOI: 10.1021/Bi035479X |
0.35 |
|
| 2004 |
Lippens G, Wieruszeski J, Leroy A, Smet C, Sillen A, Buée L, Landrieu I. Proline-directed random-coil chemical shift values as a tool for the NMR assignment of the tau phosphorylation sites. Chembiochem. 5: 73-78. PMID 14695515 DOI: 10.1002/Cbic.200300763 |
0.395 |
|
| 2004 |
Leys D, Masson C, Buée L. Angiopathies amyloïdes cérébrales Emc - Neurologie. 1: 1-7. DOI: 10.1016/S0246-0378(02)00108-2 |
0.302 |
|
| 2004 |
Maurage CA, Sambo AV, Hamdame M, Ruchoux MM, Delacourte A, Buée L. Pin1, marqueur précoce de l’agrégation des protéines tau Revue Neurologique. 160: 846. DOI: 10.1016/S0035-3787(04)71046-2 |
0.48 |
|
| 2002 |
Buée L, Hamdane M, Delobel P, Sambo A, Bégard S, Ghestem A, Sergeant N, Delacourte A. Tau story : des démences fronto-temporales aux autres tauopathies Biologie Aujourd'Hui. 196: 103-108. DOI: 10.1051/Jbio/2002196010103 |
0.368 |
|
| 1998 |
Efthimiopoulos S, Floor E, Georgakopoulos A, Shioi J, Cui W, Yasothornsrikul S, Hook VY, Wisniewski T, Buee L, Robakis NK. Enrichment of presenilin 1 peptides in neuronal large dense-core and somatodendritic clathrin-coated vesicles. Journal of Neurochemistry. 71: 2365-72. PMID 9832134 DOI: 10.1046/J.1471-4159.1998.71062365.X |
0.348 |
|
| 1997 |
Robitaille Y, Delacourte A, Sergeant N, Buée L, Veilleux F, Gauvreau D. PHENOTYPIC SUB-SETS OF LEWY BODY DEMENTIAS ARE BEST DEFINED BY DENSITIES AND NEUROANATOMICAL DISTRIBUTION OF HYPERPHOSPHORYLATED TAU ISOFORM TRIPLETS Journal of Neuropathology and Experimental Neurology. 56: 590. DOI: 10.1097/00005072-199705000-00089 |
0.366 |
|
| 1996 |
Duff K, Eckman C, Zehr C, Yu X, Prada CM, Perez-tur J, Hutton M, Buee L, Harigaya Y, Yager D, Morgan D, Gordon MN, Holcomb L, Refolo L, Zenk B, et al. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature. 383: 710-3. PMID 8878479 DOI: 10.1038/383710A0 |
0.321 |
|
| 1996 |
Hof PR, Buée-Scherrer V, Buée L, Perl DP, Delacourte A. Immunohistochemical and Biochemical Characteristics of Tau Proteins in Neurodegenerative Disorders Journal of Neuropathology and Experimental Neurology. 55: 635. DOI: 10.1097/00005072-199605000-00130 |
0.401 |
|
| 1996 |
Delacourte A, Sergeant N, Buée-Scherrer V, Buée L, David J-, Bussière T, Vermersch P, Wattez A. 6 Pathological Tau proteins are biochemical markers that differentiate several types of neurofibrillary degeneration Neurobiology of Aging. 17. DOI: 10.1016/S0197-4580(96)80008-X |
0.445 |
|
| 1995 |
Leveugle B, Ding W, Buée L, Fillit HM. Interleukin-1 and nerve growth factor induce hypersecretion and hypersulfation of neuroblastoma proteoglycans which bind β-amyloid Journal of Neuroimmunology. 60: 151-160. PMID 7642743 DOI: 10.1016/0165-5728(95)00065-A |
0.343 |
|
| 1994 |
Buée L, Hof PR, Bouras C, Delacourte A, Perl DP, Morrison JH, Fillit HM. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathologica. 87: 469-80. PMID 8059599 DOI: 10.1007/Bf00294173 |
0.443 |
|
| 1994 |
Hof PR, Nimchinsky EA, Buée-Scherrer V, Buée L, Nasrallah J, Hottinger AF, Purohit DP, Loerzel AJ, Steele JC, Delacourte A. Amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam: quantitative neuropathology, immunohistochemical analysis of neuronal vulnerability, and comparison with related neurodegenerative disorders. Acta Neuropathologica. 88: 397-404. PMID 7847067 DOI: 10.1007/Bf00389490 |
0.455 |
|
| 1994 |
Vickers JC, Riederer BM, Marugg RA, Buée-Scherrer V, Buée L, Delacourte A, Morrison JH. Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease. Neuroscience. 62: 1-13. PMID 7816192 DOI: 10.1016/0306-4522(94)90310-7 |
0.457 |
|
| 1992 |
Hof PR, Bierer LM, Perl DP, Delacourte A, Buée L, Bouras C, Morrison JH. Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia. Regional and laminar distribution of neurofibrillary tangles and senile plaques. Archives of Neurology. 49: 946-53. PMID 1520086 DOI: 10.1001/Archneur.1992.00530330070019 |
0.402 |
|
| 1992 |
Hof PR, Bouras C, Buée L, Delacourte A, Perl DP, Morrison JH. Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases. Acta Neuropathologica. 85: 23-30. PMID 1285493 DOI: 10.1007/Bf00304630 |
0.452 |
|
| 1991 |
Fillit H, Ding W, Buee L, Kalman J, Altstiel L, Lawlor B, Wolf-Klein G. Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neuroscience Letters. 129: 318-320. PMID 1745413 DOI: 10.1016/0304-3940(91)90490-K |
0.336 |
|
| 1989 |
Buee L, Laine A, Delacourte A, Flament S, Han KK. Qualitative and quantitative comparison of brain proteins in Alzheimer's disease. Biological Chemistry Hoppe-Seyler. 370: 1229-34. PMID 2514723 DOI: 10.1515/Bchm3.1989.370.2.1229 |
0.427 |
|
| Show low-probability matches. |